Literature DB >> 15024728

Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.

Nilüfer Ertekin-Taner1, Mariet Allen, Daniel Fadale, Leah Scanlin, Linda Younkin, Ronald C Petersen, Neill Graff-Radford, Steven G Younkin.   

Abstract

Risk for late onset Alzheimer disease (LOAD) and plasma amyloid beta levels (Abeta42; encoded by APP), an intermediate phenotype for LOAD, show linkage to chromosome 10q. Several strong candidate genes (VR22, PLAU, IDE) lie within the 1-lod support interval for linkage. Others have independently identified haplotypes in the chromosome 10q region harboring IDE that show highly significant association with intermediate AD phenotypes and with risk for AD. To pursue these associations, we analyzed the same haplotypes for association with plasma Abeta42 in 24 extended LOAD families and for association with LOAD in two independent case-control series. One series (MCR, 188 age-matched case-control pairs) did not show association (p=0.64) with the six haplotypes in the 276-kb region spanning three genes (IDE, KNSL1, and HHEX) previously shown to associate with LOAD. The other series (MCJ, 109 age-matched case-control pairs) showed significant (p=0.003) association with these haplotypes. In the MCJ series, the H4 (odds ratio [OR]=5.1, p=0.003) and H2(H7) haplotypes (OR=0.60, p=0.04) had the same effects previously reported. In this series, the H8 haplotype (OR=2.7, p=0.098) also had an effect similar as in one previous case control series but not in others. In the extended families, the H8 haplotype was associated with significantly elevated plasma Abeta42 (p=0.02). In addition, the H5(H10) haplotype, which is associated with reduced risk for AD in the other study is associated with reduced plasma Abeta42 (p=0.007) in our family series. These results provide strong evidence for pathogenic variant(s) in the 276-kb region harboring IDE that influence intermediate AD phenotypes and risk for AD. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024728     DOI: 10.1002/humu.20016

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  29 in total

1.  Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels.

Authors:  Christiane Reitz; Rong Cheng; Nicole Schupf; Joseph H Lee; Pankaj D Mehta; Ekaterina Rogaeva; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2010-08-17       Impact factor: 4.673

Review 2.  Neurogenetics II: complex disorders.

Authors:  A F Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

3.  New Alzheimer's disease locus on chromosome 8.

Authors:  V Giedraitis; M Hedlund; L Skoglund; E Blom; S Ingvast; R Brundin; L Lannfelt; A Glaser
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

4.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

5.  Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene.

Authors:  Xinxin Liao; Fang Cai; Zhanfang Sun; Yun Zhang; Juelu Wang; Bin Jiao; Jifeng Guo; Jinchen Li; Xixi Liu; Lina Guo; Yafang Zhou; Junling Wang; Xinxiang Yan; Hong Jiang; Kun Xia; Jiada Li; Beisha Tang; Lu Shen; Weihong Song
Journal:  JCI Insight       Date:  2020-02-27

Review 6.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

7.  In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.

Authors:  Wei-Jie Zhang; Xiao Luo; Zhan-Yun Guo
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

8.  HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.

Authors:  Sarah E Lloyd; Martin Rossor; Nick Fox; Simon Mead; John Collinge
Journal:  BMC Med Genet       Date:  2009-09-15       Impact factor: 2.103

9.  IDE (rs6583817) polymorphism and type 2 diabetes differentially modify executive function in older adults.

Authors:  G Peggy McFall; Sandra A Wiebe; David Vergote; David Westaway; Jack Jhamandas; Roger A Dixon
Journal:  Neurobiol Aging       Date:  2013-04-16       Impact factor: 4.673

10.  Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.

Authors:  Minerva M Carrasquillo; Olivia Belbin; Fanggeng Zou; Mariet Allen; Nilufer Ertekin-Taner; Morad Ansari; Samantha L Wilcox; Mariah R Kashino; Li Ma; Linda H Younkin; Samuel G Younkin; Curtis S Younkin; Toros A Dincman; Melissa E Howard; Chanley C Howell; Chloe M Stanton; Christopher M Watson; Michael Crump; Veronique Vitart; Caroline Hayward; Nicholas D Hastie; Igor Rudan; Harry Campbell; Ozren Polasek; Kristelle Brown; Peter Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Patrick G Kehoe; David M Mann; A David Smith; Helen Beaumont; Donald Warden; Clive Holmes; Reinhard Heun; Heike Kölsch; Noor Kalsheker; V Shane Pankratz; Dennis W Dickson; Neill R Graff-Radford; Ronald C Petersen; Alan F Wright; Steven G Younkin; Kevin Morgan
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.